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Abstract
During the past year, an economic crisis has affected economies and life styles throughout the
world. However, the three largest transnational tobacco companies – Philip Morris International,
British American Tobacco, and Japan Tobacco – showed excellent returns during this period,
reflecting more widespread indirect exposure to smoking.
Letter
Since September of 2008, a serious global economic reces-
sion has affected many businesses and caused widespread
unemployment. However, certain economic entities have
continued to earn profits despite the difficulties affecting
the rest of the world.
Philip Morris International (PMI), British American
Tobacco (BAT), and Japan Tobacco (JT) constitute the
three largest international manufacturers of tobacco prod-
ucts in the world, with 2007 market shares of 15.6% [1],
12.0% and 10.6% respectively [2].
PMI, separated from the Atria Group on March 28, 2008,
is currently the largest transnational tobacco company [3],
with products sold in approximately 160 countries [1]. In
2008, the cigarette sales of PMI totaled 869.7 billion, and
its gross turnover was 63.64 billion dollars, representing
increases of 2.5% and 15.2%, respectively, as compared to
the previous year [3]. BAT is the second largest interna-
tional tobacco company in the world, conducting busi-
ness in more than 180 countries and areas. Its sales
volume and gross turnover in 2008 were 715.0 billion
units and 62.82 billion dollars, representing increases of
4.5% and 25.2%, respectively, as compared to 2007 [3].
The third largest tobacco company, JT, with tobacco prod-
ucts in more than 120 countries [2], sold 614.1 billion cig-
arettes in 2008, an increase of 10.8% over the previous
year, which included 452.3 billion sold in the interna-
tional market and 161.8 billion sold in the domestic mar-
ket. The gross turnover of JT was 58.21 billion dollars, an
increase of 10.2%, as compared to the previous year [3].
The sales records of these tobacco companies demonstrate
that smokers not only continued to smoke but also actu-
ally increased their cigarette intake during this period of
economic difficulty, despite the harm to everyone caused
by exposure to this habit. Tobacco has already killed 100
million people in the 20th century, and 5.4 million deaths
per year currently result from tobacco use. In the absence
of urgent action, more than 8 million tobacco-related
deaths are predicted for every year beginning in 2030, and
approximately 1 billion tobacco-related deaths are pre-
dicted to occur during the 21st century [4]. We must inten-
sify attention on the responsibility of tobacco companies
for tobacco control.
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